MICA and neoplasm: In cervical cancer, improved prognosis was linked to the expression of MICA/B and ULBP1, whereas reduced survival (univariate analysis only) was seen when tumours were RAET1E (ULBP4)- or RAET1G (ULBP5)-positive [180].